Магнитно-резонансная томография сердца в диагностике саркоидоза
Материалы доступны только для специалистов сферы здравоохранения. Авторизуйтесь или зарегистрируйтесь.
Ключевые слова: магнитно-резонансная томография сердца, саркоидоз сердца, саркоидоз легких, эндомиокардиальная биопсия, нарушения ритма сердца.
________________________________________________
Heart sarcoidosis diagnosis presents great difficulties due to the absence of specific clinical manifestations. Most often, the diagnosis is established during autopsy. Magnetic resonance imaging (MRI) of the heart with contrast enhancement is one of the most informative methods of intravital diagnosis of cardiac sarcoidosis. In this article, two clinical cases, shows the role of MRI of the heart with contrast enhancement in the diagnosis of cardiac sarcoidosis.
Keywords: magnetic resonance imaging of the heart, sarcoidosis of the heart, sarcoidosis of the lungs, endomyovascular biopsy, heart rhythm disturbances.
2. Колосовская В.П., Адамович Н.В. Опыт организации диспансерного наблюдения больных саркоидозом в Москве. Проблемы туберкулеза. 2000;(1):7-9 [Kolosovskaya VP, Adamovich NV. The experience of organization of dispensary observation of patients with sarcoidosis in Moscow. Problemy Tuberkuleza. 2000;(1):7-9 (In Russ.)]. http://www.fesmu.ru/elib/Article.aspx?id=42683
3. Облогина Л.И., Назарычева Р.А., Быкова Н.Н. и др. Саркоидоз органов дыхания: эпидемиология, клиника, течение. В кн.: Тезисы 10-го Национального конгресса по болезням органов дыхания. Санкт-Петербург; 2005. С. 445 [Oblogina LI, Nazarycheva RA, Bykova NN, et al. Sarcoidosis of respiratory organs: epidemiology, clinical features, course. In: Tezisy 10-go Natsional’nogo kongressa po boleznyam organov dykhaniya [Abstracts of 10th National Congress on respiratory diseases]. Saint Petersburg; 2005. P. 445 (In Russ.)].
4. Визель А.А. Глава 40. Саркоидоз. В кн.: Чучалин А.Г., редактор. Пульмонология: Национальное руководство. М.: ГЭОТАР-Медиа, 2009. С. 681-95 [Vizel' AA. Chapter 40. Sarcoidosis. In: Chuchalin AG, editor. Pul’monologiya: Natsional’noe rukovodstvo [Pulmonology: National manual]. Moscow: GEOTAR-Media, 2009. P. 681-95 (In Russ.)].
5. Costabel U, Ohshimo S, Guzman J. Diagnosis of sarcoidosis: Curr Opin Pulm Med. 2008;14(5):455-61. doi: 10.1097/MCP.0b013e3283056a61
6. Hulten E, Aslam S, Osborne M, et al. Cardiac sarcoidosis – state of the art review. Cardiovasc Diagn Ther. 2016;6(1):50-63. doi: 10.3978/j.issn.2223-3652.2015.12.13
7. Perry A, Vuitch F. Causes of death in patients with sarcoidosis. A morphologic study of 38 autopsies with clinic-pathologic correlations. Arch Pathol Lab Med. 1995;119(2):167-72.
8. Baughman RP, Iannuzzi MC, Lower EE, et al. Use of fluticasone in acute symptomatic pulmonary sarcoidosis. Sarcoidosis Vasc Diff Lung Dis Off J WASOG. 2002;19(3):198-204.
9. Matsui Y, Iwai K, Tachibana T, et al. Clinicopathological study of fatal myocardial sarcoidosis. Ann N Y Acad Sci. 1976;278:455-69. doi: 10.1111/j.1749-6632.1976.tb47058.x
10. Hsia HH, Marchlinski FE. Characterization of the electroanatomic substrate for monomorphic ventricular tachycardia in patients with nonischemic cardiomyopathy. Pacing Clin Electrophysiol. 2002;25(7):1114-27. doi: 110.1046/j.1460-9592.2002.01114.x
11. Suzuki T, Kanda T, Kubota S, Imai S, Murata K. Holter monitoring as a noninvasive indicator of cardiac involvement in sarcoidosis. Chest. 1994;106(4):1021-4. doi: 10.1378/chest.106.4.1021
12. Ipek E, Demirelli S, Ermis E, Inci S. Sarcoidosis and the heart: A review of the literature. Intractable Rare Dis Res. 2015;4(4):170-80. doi: 10.5582/irdr.2015.01023
13. Mitropoulos FA, Floudas CS, Kanakis MA, Vaiopoulos GA. Cardiac sarcoidosis. Thorac Cardiovasc Surg. 2009;57(4):187-90. doi: 10.1055/s-0029-1185302
14. Lynch JP, Hwang J, Bradfield J, Fishbein M, Shivkumar K, Tung R. Cardiac involvement in sarcoidosis: evolving concepts in diagnosis and treatment. Semin Respir Crit Care Med. 2014;35(3):372-90. doi: 10.1055/s-0034-1376889
15. Birnie DH, Sauer WH, Bogun F, Cooper JM, Culver DA, Duvernoy CS, Judson MA, Kron J, Mehta D, Cosedis Nielsen J, Patel AR, Ohe T, Raatikainen P, Soejima K. HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis. Heart Rhythm. 2014;11(7):1305-23. doi: 10.1016/j.hrthm.2014.03.043
16. Стукалова О.В. Магнитно-резонансная томография сердца с отсроченным контрастированием – новый метод диагностики заболеваний сердца. Российский электронный журнал лучевой диагностики. 2013;(3):7-18 [Stukalova OV. Magnetic resonance imaging of the heart with late gadolinium enhancement – a new method of diagnosing heart disease. Rossiiskii Elektronnyi Zhurnal Luchevoi Diagnostiki. 2013;(3):7-18 (In Russ.)].
17. Orii M, Imanishi T, Akasaka T. Assessment of Cardiac Sarcoidosis with Advanced Imaging Modalities. BioMed Res Int. 2014;2014:1-15. doi: 10.1155/2014/897956
18. Mantini N, Williams B, Stewart J, Rubinsztain L, Kacharava A. Cardiac sarcoid: a clinician’s review on how to approach the patient with cardiac sarcoid. Clin Cardiol. 2012;35(7):410-5. doi: 10.1002/clc.21982
19. Синицын В.Е., Стукалова О.В., Ларина О.М., Терновой С.К. Новые возможности диагностики некоронарогенных поражений миокарда: роль магнитно-резонансной томографии. Креативная кардиология. 2008;(1):66-73 [Sinitsyn VE, Stukalova OV, Larina OM, Ternovoi SK. New potentialities of diagnosis of noncoronary lesions of the myocardium: role of magnetic resonance imaging. Kreativnaya Kardiologiya. 2008;(1):66-73 (In Russ.)]. https://elibrary.ru/item.asp?id=11838335
20. Tadamura E, Yamamuro M, Kubo S, et al. Effectiveness of delayed enhanced MRI for identification of cardiac sarcoidosis: comparison with radionuclide imaging. AJR Am J Roentgenol. 2005;185(1):110-5. doi: 10.2214/ajr.185.1.01850110
21. Vignaux O, Dhote R, Duboc D, et al. Detection of myocardial involvement in patients with sarcoidosis applying T2-weighted, contrast-enhanced, and cine magnetic resonance imaging: initial results of a prospective study. J Comput Assist Tomogr. 2002;26(5):762-7. doi: 10.1097/00004728-200209000-00017
22. Greulich S, Deluigi CC, Gloekler S, Wahl A, Zürn C, Kramer U, Nothnagel D, Bültel H, Schumm J, Grün S, Ong P, Wagner A, Schneider S, Nassenstein K, Gawaz M, Sechtem U, Bruder O, Mahrholdt H. CMR imaging predicts death and other adverse events in suspected cardiac sarcoidosis. JACC Cardiovasc Imaging. 2013;6(4):501-11. doi: 10.1016/j.jcmg.2012.10.021
________________________________________________
1. [Chuchalin AG. Sarkoidoz: Uchebno-metodicheskoe posobie dlya slushateley poslevuzovskogo i dopolnitel’nogo professional’nogo obrazovaniya [Sarcoidosis: A teaching manual for students of postgraduate and additional professional education]. Kazan; 2010. 58 р. (In Russ.)]. http://webmed.irkutsk.ru/doc/pdf/sark.pdf
2. [Kolosovskaya VP, Adamovich NV. The experience of organization of dispensary observation of patients with sarcoidosis in Moscow. Problemy Tuberkuleza. 2000;(1):7-9 (In Russ.)]. http://www.fesmu.ru/elib/Article.aspx?id=42683
3. [Oblogina LI, Nazarycheva RA, Bykova NN, et al. Sarcoidosis of respiratory organs: epidemiology, clinical features, course. In: Tezisy 10-go Natsional’nogo kongressa po boleznyam organov dykhaniya [Abstracts of 10th National Congress on respiratory diseases]. Saint Petersburg; 2005. P. 445 (In Russ.)].
4. [Pulmonology: National manual]. Moscow: GEOTAR-Media, 2009. P. 681-95 (In Russ.)].
5. Costabel U, Ohshimo S, Guzman J. Diagnosis of sarcoidosis: Curr Opin Pulm Med. 2008;14(5):455-61. doi: 10.1097/MCP.0b013e3283056a61
6. Hulten E, Aslam S, Osborne M, et al. Cardiac sarcoidosis – state of the art review. Cardiovasc Diagn Ther. 2016;6(1):50-63. doi: 10.3978/j.issn.2223-3652.2015.12.13
7. Perry A, Vuitch F. Causes of death in patients with sarcoidosis. A morphologic study of 38 autopsies with clinic-pathologic correlations. Arch Pathol Lab Med. 1995;119(2):167-72.
8. Baughman RP, Iannuzzi MC, Lower EE, et al. Use of fluticasone in acute symptomatic pulmonary sarcoidosis. Sarcoidosis Vasc Diff Lung Dis Off J WASOG. 2002;19(3):198-204.
9. Matsui Y, Iwai K, Tachibana T, et al. Clinicopathological study of fatal myocardial sarcoidosis. Ann N Y Acad Sci. 1976;278:455-69. doi: 10.1111/j.1749-6632.1976.tb47058.x
10. Hsia HH, Marchlinski FE. Characterization of the electroanatomic substrate for monomorphic ventricular tachycardia in patients with nonischemic cardiomyopathy. Pacing Clin Electrophysiol. 2002;25(7):1114-27. doi: 110.1046/j.1460-9592.2002.01114.x
11. Suzuki T, Kanda T, Kubota S, Imai S, Murata K. Holter monitoring as a noninvasive indicator of cardiac involvement in sarcoidosis. Chest. 1994;106(4):1021-4. doi: 10.1378/chest.106.4.1021
12. Ipek E, Demirelli S, Ermis E, Inci S. Sarcoidosis and the heart: A review of the literature. Intractable Rare Dis Res. 2015;4(4):170-80. doi: 10.5582/irdr.2015.01023
13. Mitropoulos FA, Floudas CS, Kanakis MA, Vaiopoulos GA. Cardiac sarcoidosis. Thorac Cardiovasc Surg. 2009;57(4):187-90. doi: 10.1055/s-0029-1185302
14. Lynch JP, Hwang J, Bradfield J, Fishbein M, Shivkumar K, Tung R. Cardiac involvement in sarcoidosis: evolving concepts in diagnosis and treatment. Semin Respir Crit Care Med. 2014;35(3):372-90. doi: 10.1055/s-0034-1376889
15. Birnie DH, Sauer WH, Bogun F, Cooper JM, Culver DA, Duvernoy CS, Judson MA, Kron J, Mehta D, Cosedis Nielsen J, Patel AR, Ohe T, Raatikainen P, Soejima K. HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis. Heart Rhythm. 2014;11(7):1305-23. doi: 10.1016/j.hrthm.2014.03.043
16. [Stukalova OV. Magnetic resonance imaging of the heart with late gadolinium enhancement – a new method of diagnosing heart disease. Rossiiskii Elektronnyi Zhurnal Luchevoi Diagnostiki. 2013;(3):7-18 (In Russ.)].
17. Orii M, Imanishi T, Akasaka T. Assessment of Cardiac Sarcoidosis with Advanced Imaging Modalities. BioMed Res Int. 2014;2014:1-15. doi: 10.1155/2014/897956
18. Mantini N, Williams B, Stewart J, Rubinsztain L, Kacharava A. Cardiac sarcoid: a clinician’s review on how to approach the patient with cardiac sarcoid. Clin Cardiol. 2012;35(7):410-5. doi: 10.1002/clc.21982
19. [Sinitsyn VE, Stukalova OV, Larina OM, Ternovoi SK. New potentialities of diagnosis of noncoronary lesions of the myocardium: role of magnetic resonance imaging. Kreativnaya Kardiologiya. 2008;(1):66-73 (In Russ.)]. https://elibrary.ru/item.asp?id=11838335
20. Tadamura E, Yamamuro M, Kubo S, et al. Effectiveness of delayed enhanced MRI for identification of cardiac sarcoidosis: comparison with radionuclide imaging. AJR Am J Roentgenol. 2005;185(1):110-5. doi: 10.2214/ajr.185.1.01850110
21. Vignaux O, Dhote R, Duboc D, et al. Detection of myocardial involvement in patients with sarcoidosis applying T2-weighted, contrast-enhanced, and cine magnetic resonance imaging: initial results of a prospective study. J Comput Assist Tomogr. 2002;26(5):762-7. doi: 10.1097/00004728-200209000-00017
22. Greulich S, Deluigi CC, Gloekler S, Wahl A, Zürn C, Kramer U, Nothnagel D, Bültel H, Schumm J, Grün S, Ong P, Wagner A, Schneider S, Nassenstein K, Gawaz M, Sechtem U, Bruder O, Mahrholdt H. CMR imaging predicts death and other adverse events in suspected cardiac sarcoidosis. JACC Cardiovasc Imaging. 2013;6(4):501-11. doi: 10.1016/j.jcmg.2012.10.021
1 Институт клинической кардиологии им. А.Л. Мясникова ФГБУ «Национальный медицинский исследовательский центр кардиологии» Минздрава России, Москва, Россия;
2 ГБУЗ «Московский городской научно-практический центр борьбы с туберкулезом» Департамента здравоохранения г. Москвы, Москва, Россия;
3 ФГАОУ ВО «Первый Московский государственный медицинский университет им. И.М. Сеченова» Минздрава России (Сеченовский Университет), Москва, Россия
________________________________________________
O.V. Stukalova 1, N.V. Meladze 1, D.A. Ivanova 2, T.M. Shvecz 2, S.A. Gaman 1, E.A. Butorova 1, R.V. Guchaev 1, M.V. Kostyukevich 1, S.K. Ternovoy 1,3
1 A.L. Myasnikov Institute of Clinical Cardiology National Cardiology Research Center of the Ministry of Health of the Russian Federation, Moscow, Russia;
2 Moscow Scientific and Clinical Center for TB Control, Moscow, Russia;
3 I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University), Moscow, Russia;